Lisa Foster’s Post

In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that unfortunately, the U.S. has fallen behind countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, where women are empowered to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US). Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that unfortunately, the U.S. has fallen behind countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, where women are empowered to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US). Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that unfortunately, the U.S. has fallen behind countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, where women are empowered to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US). Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, have empowered women to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US.) The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, have empowered women to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US.) The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, have empowered women to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US.) The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

Equally viable and effective, self-collection solutions allow women to collect their own samples without clinician assistance, and in some cases, from the privacy of their homes, foregoing not only the inconvenience but also the added expenses and discomfort often associated with in-person pelvic exams. Self-collection is less invasive. It does not require stirrups and a speculum – just a small swab. In this Medical Product Outsourcing op-ed by Dr. Jeff Andrews, Vice President of Medical Affairs for Integrated Diagnostic Solutions at BD Life Sciences, notes that countries like Denmark, Sweden, the Netherlands, Kenya, Australia and New Zealand, just to name a few, have empowered women to self-collect for cervical cancer screening. (The FDA has not yet approved self-collection tests for cervical cancer screening in the US.) The more women can get screened, the more we can detect precancer early and prevent cervical cancer. Let’s work together to address the lack of access to health care that persists around the world. #CervicalCancerAwarenessMonth #SelfCollection #CervicalCancerPrevention #EquitableHealthCare #BDemployee

NEW ISSUE ALERT 📢 Check out the latest issue of the Journal of Clinical Pathways! https://lnkd.in/e7PYuSnj Featured stories include: Anna Bolha, et al discuss a real-world study of treatment selection patterns across American Oncology Network medical oncologists, which analyzed pathway adherence rates before and after a pilot project where Evolent level 1 pathways were integrated into Flatiron Assist, an electronic health record-embedded clinical decision support tool in OncoEMR. Ray Page, DO, PhD, FACOI, FASCO, describes how congruent solutions for treatment options can be achieved if the objectives of precision medicine and treatment pathways are aligned. Dennis Holmes, MD, et al, explore how clinical pathways can help reduce time to treatment delays while improving health care quality, lowering direct and indirect health care costs, reducing patient financial toxicity, and achieving greater patient, provider, and payer satisfaction. Lee Blansett, MBA, HMP Market Access Insights focuses on provider-implemented pathways in provider organizations and their association with other internal structures and processes within a wide range of organizations providing treatment to patients with cancer. #Journalofclinicalpathways #JCP #Valuebasedcare #CancerCare #HMPMarketAccessInsights #Flatiron #OncoEMR #AmericanOncologyNetwork #Precisionmedicine #EHR

Attending #ISOQOL in Cologne? Connect with our Patient Centred Outcomes experts in booth 9 to discuss tailored solutions for putting the patient voice first in drug and device development. Be sure to attend these poster presentations too: • Exploring the patient experience of advanced and/or metastatic hepatocellular carcinoma: a multi-stage study, 14 October, 3:30pm – 4:10pm • Data collection and analysis in longitudinal qualitative research (LQR) to understand change over time, 15 October, 9:35am -10:15am • Development of a conceptual model of the patient experience of disease activity in cutaneous lupus erythematosus, 16 October, 9:30am – 10:10am Join us: https://ow.ly/W8el50TqWxU

May is #BladderCancer Awareness Month 📣 And we are passionate about bringing you the latest news & updates 🎥 🗞️ "For final analysis [of AMBASSADOR] we see that adjuvant #pembrolizumab is very active, and it's a treatment option for our patients now with muscle invasive #urothelialcarcinoma in the adjuvant setting that are at high risk. So I think that these findings are very exciting and offering a new treatment option for our patients in this setting." 💡 Learn more from Andrea Apolo, MD, National Institutes of Health, Bethesda, MD 👉 https://lnkd.in/eFwV4Abt #VJOncology #BladderCancerAwarenessMonth